REVVITY, INC Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments
REVVITY, INC (RVTY) reported Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments of -$4.80 million for the 3-month period ending 2021-10-03, per its 10-Q filed 2021-11-09.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments · last filed 2021-11-09
- REVVITY, INC gain (loss) on foreign currency derivative instruments not designated as hedging instruments for the quarter ending 2021-10-03 was -$4.80M.
- REVVITY, INC gain (loss) on foreign currency derivative instruments not designated as hedging instruments for the quarter ending 2021-07-04 was -$3.30M.
- REVVITY, INC gain (loss) on foreign currency derivative instruments not designated as hedging instruments for the quarter ending 2021-04-04 was $4.70M, a 51.04% decline year-over-year.
- REVVITY, INC gain (loss) on foreign currency derivative instruments not designated as hedging instruments for the quarter ending 2021-01-03 was $9.60M.
- REVVITY, INC gain (loss) on foreign currency derivative instruments not designated as hedging instruments for fiscal 2021 was $7.70M.
- REVVITY, INC gain (loss) on foreign currency derivative instruments not designated as hedging instruments for fiscal 2019 was -$3.50M, a 129.91% decline from fiscal 2018.
- REVVITY, INC gain (loss) on foreign currency derivative instruments not designated as hedging instruments for fiscal 2018 was $11.70M.
- REVVITY, INC gain (loss) on foreign currency derivative instruments not designated as hedging instruments for fiscal 2017 was -$4.50M, a 183.33% decline from fiscal 2017.
| Period end | Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments 3 month | Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments 6 month | Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments 9 month | Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments 12 month | Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments 12 month as first filed |
|---|---|---|---|---|---|
| 2021-10-03 | -$4.80M 10-Q · filed 2021-11-09 | -$8.10M derived: sum of 2 quarters · filed 2021-11-09 | -$3.30M 10-Q · filed 2021-11-09 | $6.20M derived: sum of 4 quarters · filed 2021-11-09 | |
| 2021-07-04 | -$3.30M 10-Q · filed 2021-08-10 | $1.50M 10-Q · filed 2021-08-10 | $11.00M derived: sum of 3 quarters · filed 2021-08-10 | $5.00M derived: sum of 4 quarters · filed 2021-11-09 | |
| 2021-04-04 | $4.70M 10-Q · filed 2021-05-11 | $14.30M derived: sum of 2 quarters · filed 2021-05-11 | $8.30M derived: sum of 3 quarters · filed 2021-11-09 | $700.00K derived: sum of 4 quarters · filed 2021-11-09 | |
| 2021-01-03 | $9.60M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02 | $3.60M derived: sum of 2 quarters · filed 2021-11-09 | -$4.00M derived: sum of 3 quarters · filed 2021-11-09 | $7.70M 10-K · filed 2021-03-02 | |
| 2020-10-04 | -$6.00M 10-Q · filed 2021-11-09 | -$13.60M derived: sum of 2 quarters · filed 2021-11-09 | -$1.90M 10-Q · filed 2021-11-09 | -$11.70M derived: sum of 4 quarters · filed 2021-11-09 | |
| 2020-07-05 | -$7.60M 10-Q · filed 2021-08-10 | $4.00M 10-Q · filed 2021-08-10 | -$5.70M derived: sum of 3 quarters · filed 2021-08-10 | -$1.47M derived: sum of 4 quarters · filed 2021-08-10 | |
| 2020-04-05 | $9.60M 10-Q · filed 2021-05-11 | $1.90M derived: sum of 2 quarters · filed 2021-05-11 | $6.13M derived: sum of 3 quarters · filed 2021-05-11 | $6.33M derived: sum of 4 quarters · filed 2021-05-11 | |
| 2019-12-29 | -$7.70M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02 | -$3.47M derived: sum of 2 quarters · filed 2021-03-02 | -$3.27M derived: sum of 3 quarters · filed 2021-03-02 | -$3.50M 10-K · filed 2021-03-02 | |
| 2019-09-29 | $4.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $4.43M derived: sum of 2 quarters · filed 2020-11-10 | $4.20M 10-Q · filed 2020-11-10 | $25.63M derived: sum of 4 quarters · filed 2021-03-02 | |
| 2019-06-30 | $200.00K 10-Q · filed 2020-08-11 | -$27.00K 10-Q · filed 2020-08-11 | $21.40M derived: sum of 3 quarters · filed 2021-03-02 | $23.90M derived: sum of 4 quarters · filed 2021-03-02 | |
| 2019-03-31 | -$300.00K 10-Q · filed 2020-05-12 | $21.20M derived: sum of 2 quarters · filed 2021-03-02 | $23.70M derived: sum of 3 quarters · filed 2021-03-02 | $34.00M derived: sum of 4 quarters · filed 2021-03-02 | |
| 2018-12-30 | $21.50M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02 | $24.00M derived: sum of 2 quarters · filed 2021-03-02 | $34.30M derived: sum of 3 quarters · filed 2021-03-02 | $11.70M 10-K · filed 2021-03-02 | |
| 2018-09-30 | $2.50M 10-Q · filed 2019-11-05 | $12.80M derived: sum of 2 quarters · filed 2019-11-05 | -$9.80M 10-Q · filed 2019-11-05 | -$48.70M derived: sum of 4 quarters · filed 2020-02-25 | |
| 2018-07-01 | $10.30M 10-Q · filed 2019-08-06 | -$12.30M 10-Q · filed 2019-08-06 | -$51.20M derived: sum of 3 quarters · filed 2020-02-25 | -$18.50M derived: sum of 4 quarters · filed 2020-02-25 | |
| 2018-04-01 | -$22.60M 10-Q · filed 2019-05-07 | -$61.50M derived: sum of 2 quarters · filed 2020-02-25 | -$28.80M derived: sum of 3 quarters · filed 2020-02-25 | -$24.70M derived: sum of 4 quarters · filed 2020-02-25 | |
| 2017-12-31 | -$38.90M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | -$6.20M derived: sum of 2 quarters · filed 2020-02-25 | -$2.10M derived: sum of 3 quarters · filed 2020-02-25 | -$4.50M 10-K · filed 2020-02-25 | |
| 2017-10-01 | $32.70M 10-Q · filed 2018-11-06 | $36.80M derived: sum of 2 quarters · filed 2018-11-06 | $34.40M 10-Q · filed 2018-11-06 | $40.90M derived: sum of 4 quarters · filed 2019-02-26 | |
| 2017-07-02 | $4.10M 10-Q · filed 2018-08-07 | $1.70M 10-Q · filed 2018-08-07 | $8.20M derived: sum of 3 quarters · filed 2019-02-26 | $6.10M derived: sum of 4 quarters · filed 2019-02-26 | |
| 2017-04-02 | -$2.40M 10-Q · filed 2018-05-08 | $4.10M derived: sum of 2 quarters · filed 2019-02-26 | $2.00M derived: sum of 3 quarters · filed 2019-02-26 | $200.00K derived: sum of 4 quarters · filed 2019-02-26 | |
| 2017-01-01 | $6.50M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $4.40M derived: sum of 2 quarters · filed 2019-02-26 | $2.60M derived: sum of 3 quarters · filed 2019-02-26 | $5.40M 10-K · filed 2019-02-26 | |
| 2016-10-02 | -$2.10M 10-Q · filed 2017-11-07 | -$3.90M derived: sum of 2 quarters · filed 2017-11-07 | -$1.10M 10-Q · filed 2017-11-07 | -$41.60M derived: sum of 4 quarters · filed 2018-02-27 | |
| 2016-07-03 | -$1.80M 10-Q · filed 2017-08-08 | $1.00M 10-Q · filed 2017-08-08 | -$39.50M derived: sum of 3 quarters · filed 2018-02-27 | -$43.00M derived: sum of 4 quarters · filed 2018-02-27 | |
| 2016-04-03 | $2.80M 10-Q · filed 2017-05-09 | -$37.70M derived: sum of 2 quarters · filed 2018-02-27 | -$41.20M derived: sum of 3 quarters · filed 2018-02-27 | -$33.40M derived: sum of 4 quarters · filed 2018-02-27 | |
| 2016-01-03 | -$40.50M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | -$44.00M derived: sum of 2 quarters · filed 2018-02-27 | -$36.20M derived: sum of 3 quarters · filed 2018-02-27 | -$20.60M 10-K · filed 2018-02-27 | $20.80M 10-K · filed 2016-03-01 |
| 2015-10-04 | -$3.50M 10-Q · filed 2016-11-08 | $4.30M derived: sum of 2 quarters · filed 2016-11-08 | $19.90M 10-Q · filed 2016-11-08 | ||
| 2015-06-28 | $7.80M 10-Q · filed 2016-08-09 | $23.30M 10-Q · filed 2016-08-09 | |||
| 2015-03-29 | $15.50M 10-Q · filed 2016-05-10 | ||||
| 2014-12-28 | -$200.00K 10-K · filed 2017-02-28 | $200.00K 10-K · filed 2016-03-01 | |||
| 2013-12-29 | $1.40M 10-K · filed 2016-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |